Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Daunorubicin × Clear all

Phase

Status

Completed 33 Active not recruiting 3 Withdrawn 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

OTHER 12 NIH 11 INDUSTRY 2 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 14 Paclitaxel 11 Cyclophosphamide 9 Taxes 8 Carboplatin 8 Platinum 6 Gemcitabine 6 1,2-diaminocyclohexaneplatinum II citrate 6 Doxorubicin 5 Cytarabine 5 Brachytherapy 5 fludarabine 4 Trastuzumab 4 Rituximab 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy 4 Oxaliplatin 4 Fluorouracil 4 Docetaxel 4 Capecitabine 4 Watchful Waiting 3 Radiosurgery 3 Pemetrexed 3 Nimorazole 3 Imatinib Mesylate 3 Idarubicin 3 Gene Expression Profiling 3 thymoglobulin 2 regorafenib 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01145846 2010-06-17

AIvsAD

Cooperative Study Group A for Hematology

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡